UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Limitation of Accessing Hospital Services Due to COVID-19 Pandemic: A Pilot Study of the Telephone Triage to Re-Organize the Access to a Center for Sexual Health in Northwest Italy

Sexually transmitted diseases, 2023-09, Vol.50 (9), p.603-606

2023

Volltextzugriff (PDF)

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study

Acta dermato-venereologica, 2023-04, Vol.103, p.adv5278-adv5278

2023

Volltextzugriff (PDF)

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy

Acta dermato-venereologica, 2022-11, Vol.102, p.adv00821-adv00821

2022

Volltextzugriff (PDF)

Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4561

2021

Volltextzugriff (PDF)

Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients

Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (7), p.883

2022

Volltextzugriff (PDF)

Alopecia areata after COVID-19 vaccination

Clinical and Experimental Vaccine Research , 2022, 11(1), , pp.129-132

2022

Volltextzugriff (PDF)

Editorial: Patients-oriented treatments for chronic inflammatory skin diseases

Frontiers in medicine, 2024-09, Vol.11, p.1473753

2024

Volltextzugriff (PDF)

Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer

Frontiers in medicine, 2023-02, Vol.9, p.959289-959289

2023

Volltextzugriff (PDF)

SPECT/CT-Guided Surgical Removal of a Positive External Iliac Sentinel Node in Primary Umbilical Melanoma: Report of a Case, and Up-to-Date Review of the Literature

Frontiers in oncology, 2022-01, Vol.11, p.772771

2022

Volltextzugriff (PDF)

Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study

Acta dermato-venereologica, 2022-04, Vol.102, p.adv00687-adv00687

2022

Volltextzugriff (PDF)

Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report

Acta dermato-venereologica, 2021-05, Vol.101 (5), p.adv00452-adv00452

2021

Volltextzugriff (PDF)

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Dermatology reports, 2022-03, Vol.14 (3)

2022

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study

Cosmetics (Basel), 2023-11, Vol.10 (6), p.153

2023

Volltextzugriff (PDF)

Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis

Cosmetics (Basel), 2023-12, Vol.11 (1), p.3

2023

Volltextzugriff (PDF)

A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts

Dermatology and therapy, 2020-10, Vol.10 (5), p.1063-1073

2020

Volltextzugriff (PDF)

Response to Letter to the Editor Regarding “A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts”

Dermatology and therapy, 2020-12, Vol.10 (6), p.1439-1440

2020

Volltextzugriff (PDF)

Einfluss von Alkoholabusus und Lebensstil bei Patienten mit Psoriasis auf das Ansprechen auf IL‐17‐ und IL‐23‐Inhibitoren

Journal der Deutschen Dermatologischen Gesellschaft, 2024-09, Vol.22 (9), p.1233-1242

2024

Volltextzugriff (PDF)

51352 Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB185-AB185

2024

Volltextzugriff (PDF)

Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis

Journal der Deutschen Dermatologischen Gesellschaft, 2024-01, Vol.22 (1), p.34-44

2024

Volltextzugriff (PDF)

Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis: Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment

Journal der Deutschen Dermatologischen Gesellschaft, 2024-01, Vol.22 (1), p.34-44

2024

Volltextzugriff (PDF)

Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatment

Expert opinion on biological therapy, 2023-09, Vol.23 (9), p.1-868

2023

Volltextzugriff (PDF)

Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?

International journal of dermatology, 2022-10, Vol.61 (10), p.e370-e372

2022

Volltextzugriff (PDF)

Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis

Dermatologic therapy, 2022-05, Vol.35 (5), p.e15407-n/a

2022

Volltextzugriff (PDF)

Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series

Journal of the European Academy of Dermatology and Venereology, 2024-10, Vol.38 (10), p.e852-e854

2024

Volltextzugriff (PDF)

Long‐term psychological outcome of patients with moderate‐to‐severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years

Experimental dermatology, 2023-06, Vol.32 (6), p.852-858

2023

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(109)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The Limitation of Accessing Hospital Services Due to COVID-19 Pandemic: A Pilot Study of the Telephone Triage to Re-Organize the Access to a Center for Sexual Health in Northwest Italy

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy

Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications

Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients

Alopecia areata after COVID-19 vaccination

Editorial: Patients-oriented treatments for chronic inflammatory skin diseases

Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer

SPECT/CT-Guided Surgical Removal of a Positive External Iliac Sentinel Node in Primary Umbilical Melanoma: Report of a Case, and Up-to-Date Review of the Literature

Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study

Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study

Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis

A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts

Response to Letter to the Editor Regarding “A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts”

Einfluss von Alkoholabusus und Lebensstil bei Patienten mit Psoriasis auf das Ansprechen auf IL‐17‐ und IL‐23‐Inhibitoren

51352 Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years

Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis

Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatment

Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?

Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis

Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series

Long‐term psychological outcome of patients with moderate‐to‐severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years

Suchergebnisse filtern